🇺🇸 FDA
Patent

US 8647842

Methods for producing a fusion protein capable of binding VEGF

granted A61KA61K38/00A61P

Quick answer

US patent 8647842 (Methods for producing a fusion protein capable of binding VEGF) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61P, A61P43/00